Puma Pumps up Biotech ETFs
July 23, 2014 at 11:45 AM EDT
Shares of Puma Biotechnology (NYSE: PBYI) are up more than 277% Wednesday on volume that is already better than 10 times the daily average after the company said its experimental breast cancer treatment, neratinib, proved successful in a Phase III trial. “The primary endpoint of the trial was...